Forair 125/Forair 250 Dosage & Drug Information

Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Storage MIMS Class ATC Classification Regulatory Classification Presentation/Packing

Concise Prescribing Info

Contents

Per 25/125 mcg MDI Salmeterol xinafoate 25 mcg, fluticasone propionate 125 mcg. Per 25/250 mcg MDI Salmeterol xinafoate 25 mcg, fluticasone propionate 250 mcg

Indications/Uses

Regular treatment of asthma & airflow obstruction in patients w/ COPD associated w/ chronic bronchitis.

Click to view Forair 125/Forair 250 detailed prescribing information

Dosage/Direction for Use

Adult & adolescent ≥12 yr 2 inhalations bid.

Click to view Forair 125/Forair 250 detailed prescribing information

Overdosage

View Forair 125/Forair 250 overdosage for action to be taken in the event of an overdose.

Contraindications

Acute bronchospasm. Primary treatment of status asthmaticus or other acute episodes.

Click to view Forair 125/Forair 250 detailed prescribing information

Special Precautions

Avoid abrupt w/drawal. Pulmonary TB, severe CV disorders including heart rhythm abnormalities, existing or history of DM, untreated hypokalemia or thyrotoxicosis. Discontinue use if paradoxical bronchospasm occurs. Increased risk of systemic effects w/ high doses for prolonged period & concomitant use w/ other potent CYP3A4 inhibitors. Regularly monitor height of childn during prolonged use. Pregnancy & lactation. Elderly.

Click to view Forair 125/Forair 250 detailed prescribing information

Use In Pregnancy & Lactation

Click to view Forair 125/Forair 250 detailed prescribing information

Adverse Reactions

Nausea, dizziness, arthralgia, rash, hyperglycemia. Hoarseness of voice/dysphonia, throat irritation, headache, candidiasis of the mouth & throat. Adrenal suppression, decreased bone mineral density.

Click to view Forair 125/Forair 250 detailed prescribing information

Drug Interactions

Increased plasma conc w/ ritonavir. TCAs, MAOIs, β-adrenergic receptor blockers, thiazide or K-depleting diuretics, ketoconazole or CYP450 inhibitors.

Click to view Forair 125/Forair 250 detailed prescribing information

Storage

View Forair 125/Forair 250 storage conditions for details to ensure optimal shelf-life.

Description

View Forair 125/Forair 250 description for details of the chemical structure and excipients (inactive components).

Action

View Forair 125/Forair 250 mechanism of action for pharmacodynamics and pharmacokinetics details.

MIMS Class

Antiasthmatic & COPD Preparations

ATC Classification

R03AK06 - salmeterol and fluticasone ; Belongs to the class of adrenergics in combination with corticosteroids or other drugs, excluding anticholinergics. Used in the treatment of obstructive airway diseases.

Regulatory Classification

Presentation/Packing

Form

Forair 125 MDI

Packing/Price

1's (P414.4/canister)

Form

Forair 250 MDI

Packing/Price

1's (P599.2/canister)

Forair 125/Forair 250

salmeterol + fluticasone

Manufacturer:

Zydus Healthcare

Distributor:

Zydus Healthcare